![](/img/cover-not-exists.png)
Phase II Study of Temozolomide in Relapsed or Refractory High-Risk Neuroblastoma: A Joint Societe Francaise des Cancers de l'Enfant and United Kingdom Children Cancer Study Group New Agents Group Study
Rubie, H., Chisholm, J., Defachelles, A. S., Morland, B., Munzer, C., Valteau-Couanet, D., Mosseri, V., Bergeron, C., Weston, C., Coze, C., Auvrignon, A., Djafari, L., Hobson, R., Baunin, C., DickinsoVolume:
24
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.06.1572
Date:
January, 2006
File:
PDF, 89 KB
english, 2006